Fine tuning prostate cancer diagnostics

Professor Armando Stabile discusses the latest advancements and precision methods in fine tuning prostate cancer diagnostics at the EAU 2026 Annual Congress.

How imaging is shaping prostate cancer management

Professor Giovanni Lughezzani discusses the transformative role of imaging in shaping the management of prostate cancer at the EAU 2026 Annual Congress.

Navigating the future of urologic care: Trials in progress

Professor Tyler M. Seibert discusses the upcoming breakthroughs and ongoing clinical trials navigating the future of urologic care at the EAU 2026 Annual Congress.

Kidney stones made simple: A comprehensive update for all urologists

Professor Mariela Corrales Acosta provides a comprehensive update on kidney stone management, simplifying complex clinical challenges for all urologists at the EAU 2026 Annual Congress.

Kidney stones made simple: Best clinical practice and preventing complications

Professor Begoña Ballesta Martínez provides a comprehensive update for all urologists, focusing on best clinical practices and strategies for preventing complications in kidney stone management at EAU 2026.

Advancing BPO treatment: From aquablation to enucleation

Professor Bogdan Florin Geavlete explores the evolution of BPO treatment, covering advancements from aquablation to enucleation techniques at the EAU 2026 Annual Congress.

How imaging is shaping prostate cancer management: Screening and early detection

Professor Laurence H. Klotz discusses the promising trends in screening and early detection, highlighting how imaging is shaping the future of prostate cancer management at the EAU 2026 Annual Congress.

Retroperitoneal lymph dissection considerations in testicular cancer

Professor Anna Thor discusses the critical clinical considerations and surgical nuances of retroperitoneal lymph node dissection in the management of testicular cancer at the EAU 2026 Annual Congress.

Prostate cancer: PARPIs finally explained

Professor Alexander W. Wyatt breaks down the complexities of PARP inhibitors (PARPIs), providing a clear and comprehensive explanation of their role in treating prostate cancer at the EAU 2026 Annual Congress.

From MRI to Post-treatment care: prostate cancer screening

Professor Hendrik Van Poppel discusses the complete pathway of prostate cancer screening, from the initial role of MRI to the nuances of post-treatment care at the EAU 2026 Annual Congress.

Navigating the future of urologic care

Professor Andreas Røder discusses the evolving landscape and strategic shifts navigating the future of urologic care at the EAU 2026 Annual Congress.

Antibiotics & renal health: Striking the perfect balance between benefit and risk

Professor Merel M.C. Lambregts discusses the delicate clinical challenge of antibiotics and renal health, exploring how to strike the perfect balance between therapeutic benefit and potential risk at the EAU 2026 Annual Congress.

Infections: Prophylactic antibiotics in renal cancer surgery - Safeguarding patients from postoperative infection

Professor Florian M. E. Wagenlehner discusses the critical role of prophylactic antibiotics in renal cancer surgery and effective strategies for safeguarding patients from postoperative infections at the EAU 2026 Annual Congress.

2026 EAU Guidelines update and controversies – Urolithiasis, female and male LUTS and infections: What has changed?

Professor Arjun Konath Nambiar provides a critical update on the 2026 EAU Guidelines, exploring the latest changes and ongoing controversies in urolithiasis, male and female LUTS, and urological infections at the EAU 2026 Annual Congress.

Progression-free survival following primary staging with [¹⁸F]PSMA-1007 PET/ceCT versus Na[¹⁸F]F-PET/ceCT in prostate cancer: Results from the PRISMA PET randomized controlled trial

Karen Middelbo Buch-Olsen and Mads Hvid Poulsen present the highly anticipated results from the PRISMA PET randomized controlled trial, comparing progression-free survival in prostate cancer staging between [¹⁸F]PSMA-1007 PET/ceCT and Na[¹⁸F]F-PET/ceCT at the EAU 2026 Annual Congress.

Redefining EMBARK-like Patients in the PSMA Era: Impact of PSMA-PET Restaging on Disease Classification and Management

Professor Alessandro Viti discusses the impact of PSMA-PET restaging on disease classification and management, redefining "EMBARK-like" patients in the modern PSMA era at the EAU 2026 Annual Congress.

A new era in pelvic node dissection in prostate cancer

What are the real benefits for robotic prostatectomy

How and when to treat BCG failure

Alternatives to cystectomy in MIBC

European Urology Scholarship Programme (EUSP) Lecture

How to prepare a good paper

EAU vision for the future

Role of the Hungarian Urology in Europe

Biochemical tests to identify aggressive disease

AS in SRM

Treatment of metastatic RCC

Limits of surgery in metastatic kidney cancer: How far can we go?

Treatment algorithms in CRPC

Organ preservation in testicular cancer: Fact or fiction?

Highlights from the 30th Anniversary EAU Congress in Madrid 2015

Welcome to EAU CEM15